Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PharmAsia News' Top Industry Trends Of 2009

This article was originally published in PharmAsia News

Executive Summary

As PharmAsia News wraps up its second year of publishing, we look back to some of the top trends and stories of 2009, as well as developing stories to keep an eye on in 2010

You may also be interested in...

China Boosts Health System Reforms With Expanded National Drug Reimbursement List

BEIJING - In the government's latest move to expand coverage under sweeping health system reforms that are in the works China-wide, the Ministry of Human Resources and Social Security has added hundreds of new medicines to the latest edition of the national drug reimbursement catalog

Investment Outlook For China And India Too Hot? VCs Anticipate Market Corrections - PharmAsia Summit

SAN FRANCISCO - Investors have not felt the pinch of the financial crisis in China and India as much as they have in the West, investors told PharmAsia Summit attendees in San Francisco Oct. 28

Partnering Better Than Solo Play For Biosimilars, Says Dr. Reddy's CEO; Limited Growth In Generics Will Lead To Moves For Innovative Drugs

MUMBAI - With six biosimilar compounds in the works and two launched in the Indian market, India's second largest generic drug maker - Dr. Reddy's Labs - is negotiating with several multinational companies to broaden its presence in Western markets

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts